King Oyster Polysaccharides and Immune Modulation

King Trumpet / King Oyster Immunity

β-1,6-glucan: king oyster's structurally unique polysaccharide

Wang and colleagues documented in a 2022 Frontiers in Immunology study that Pleurotus eryngii produces β-1,6-glucan, structurally distinct from the β-1,3-glucan that most medicinal mushrooms use as their primary immune compound. This β-1,6-glucan modulates both immune function and gut microbiota composition.

Wang et al., Frontiers in Immunology, 2022

NF-κB + MAPK

the signaling pathways activated by P. eryngii β-glucan in macrophages: NF-κB, ERK1/2, JNK, and p38 MAPK; the sulfated derivative showed enhanced immunostimulatory activity (Kim et al., IJMM, 2017)

Protein fraction too

a novel protein isolated from P. eryngii reduced NO, PGE2, and COX-2 in LPS-stimulated macrophages, an anti-inflammatory effect distinct from polysaccharide-mediated immune activation (Yuan et al., Food & Function, 2017)

Waste still works

polysaccharides from P. eryngii processing residue inhibited tumor growth and upregulated NK cell activity and macrophage phagocytosis in mouse models (Ma et al., Carbohydrate Polymers, 2014)

Wang et al., Frontiers in Immunology, 2022

View as image ↗

When people discuss beta-glucans in medicinal mushrooms, they almost always mean beta-1,3-glucan, the polysaccharide backbone found in reishi, turkey tail, lion's mane, and most other species studied for immune effects. It binds to Dectin-1 receptors on macrophages and initiates the innate immune cascade.

King oyster mushroom (Pleurotus eryngii) works differently. A 2022 study in Frontiers in Immunology documented that P. eryngii's primary polysaccharide fraction is not beta-1,3-glucan but beta-1,6-glucan, a structurally distinct polymer with a different branching pattern, different receptor affinity, and an immune profile that includes effects on gut microbiota composition in addition to the standard immune cell activation.^[1]

This structural distinction is unknown to essentially all consumer health content on king oyster mushroom. The practical implications are still being researched, but the finding establishes that P. eryngii's polysaccharide immune mechanism is not simply a copy of what other medicinal mushrooms do.

For the pillar overview of king oyster's general profile, see what is king trumpet mushroom: the meaty mushroom with health benefits. For the broader immune health context, see king trumpet and the immune system: research review.

The β-1,6-Glucan Discovery: What Makes This Structurally Different

In most medicinal mushrooms with documented immune effects, the active polysaccharide has a β-1,3-glycosidic backbone: glucose units connected at the 1-3 positions of the ring, often with β-1,6-linked branches. This structure is recognized by the pattern recognition receptor Dectin-1 on macrophages and dendritic cells, triggering the downstream cascade of innate immune activation.

P. eryngii's primary immune-active polysaccharide, as characterized by Wang and colleagues in 2022, has a β-1,6-linked backbone instead.^[1] In a β-1,6-glucan, the glucose units are connected at the 1-6 positions, producing a more flexible, less rigid chain with different three-dimensional geometry and, consequently, different receptor binding properties.

The Wang 2022 paper also documented that this β-1,6-glucan does not just activate immune cells; it also positively modulates gut microbiota composition. This second action connects the immunomodulatory effects to the gut-immune axis, a pathway through which gut bacteria influence systemic immune function. This dual effect has not been documented for the β-1,3-glucans in most other medicinal mushrooms in the same study context.

The structural difference matters for understanding why P. eryngii's immune effects may not be identical to those of reishi, turkey tail, or lion's mane despite all being "mushroom beta-glucans." The receptor binding differences translate into potentially different downstream immune profiles.

The Macrophage Signaling Cascade

Kim and colleagues characterized the macrophage signaling response to P. eryngii's extracellular β-glucan in 2017, using a well-established macrophage cell line to map which signaling pathways were activated.^[2]

The extracellular β-glucan fraction activated four signaling pathways in macrophages:

NF-κB (Nuclear Factor kappa B): The master transcription factor for innate immunity. NF-κB activation triggers expression of pro-inflammatory cytokines, adhesion molecules, and immune-activating enzymes. It is a central switch for macrophage activation.

ERK1/2 (Extracellular signal-Regulated Kinases): Part of the MAPK (mitogen-activated protein kinase) family. ERK1/2 activation promotes cell survival, proliferation, and cytokine production in macrophages.

JNK (c-Jun N-terminal Kinase): Another MAPK family member. JNK activation is involved in macrophage responses to stress and inflammatory stimuli, contributing to pro-inflammatory cytokine production.

p38 MAPK: The third MAPK pathway activated. p38 coordinates inflammatory responses and cytokine production alongside NF-κB.

All four pathways being activated simultaneously reflects comprehensive macrophage activation rather than a narrow or partial response. The study also tested a sulfated form of the β-glucan, in which sulfate groups are chemically added to the polysaccharide backbone. The sulfated derivative showed enhanced immunostimulatory activity compared to the parent compound, suggesting that chemical modification can further tune the immune response.

For how P. eryngii's macrophage activation compares to other species, see how medicinal mushrooms activate macrophages.

Anti-Inflammatory Alongside Immunostimulatory: The Same Mushroom, Different Fractions

An apparent paradox in P. eryngii research is that its polysaccharides appear to be both immunostimulatory (activating macrophages, NK cells) and anti-inflammatory (reducing inflammatory markers in macrophages). This seems contradictory until you recognize that different polysaccharide fractions from the same mushroom can have different activities.

Ma and colleagues characterized a specific polysaccharide fraction from P. eryngii in 2020 and tested it in THP-1 cells, a human macrophage cell line.^[3] This fraction reduced the production of IL-1β (a pro-inflammatory cytokine) and nitric oxide (a reactive molecule produced during inflammation) in LPS-stimulated macrophages, demonstrating anti-inflammatory rather than pro-inflammatory activity.

The key word is "fraction." P. eryngii contains a complex mixture of polysaccharides with different structures and different biological targets. The β-1,6-glucan documented by Wang 2022 has immunomodulatory activity affecting immune cells and gut microbiota. The fraction characterized by Ma 2020 has anti-inflammatory activity in macrophages stimulated by bacterial signals. The extracellular β-glucan characterized by Kim 2017 activates the macrophage MAPK cascade.

Zhang and colleagues' comprehensive review of P. eryngii polysaccharide research in 2020 documented this complexity explicitly: extraction method determines which fractions are recovered, and different fractions have distinct immunological activities.^[4] Hot-water extraction, alkaline extraction, and ultrasound-assisted methods yield structurally different polysaccharides with different biological profiles.

This is why statements like "king oyster beta-glucans boost immunity" are incomplete. The activity depends on which fraction is being discussed.

The Protein Fraction: Immune Effects Beyond Polysaccharides

A 2017 study by Yuan and colleagues identified a novel protein isolated from P. eryngii fruiting bodies with significant anti-inflammatory activity in macrophages.^[5]

This protein reduced the production of:

• Nitric oxide (NO), a signaling molecule involved in inflammation
• Prostaglandin E2 (PGE2), a lipid mediator that amplifies pain and inflammation
• COX-2 (cyclooxygenase-2), the enzyme that produces prostaglandins from arachidonic acid

COX-2 inhibition is the mechanism of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. A protein from P. eryngii that reduces COX-2 activity in macrophages represents an anti-inflammatory mechanism that operates independently of the polysaccharide fractions.

The finding establishes that P. eryngii's immune and anti-inflammatory effects involve at least two distinct molecular classes: polysaccharides (beta-glucans) and proteins. This matters for how supplements are evaluated: a product that contains only extracted polysaccharides will lack the protein fraction's activity, while a whole-mushroom powder retains both.

NK Cell Activation and Tumor Models

The in vivo tumor model data for P. eryngii polysaccharides extends the macrophage findings into a more complex biological context.

Ma and colleagues investigated polysaccharides derived from P. eryngii processing residue (the parts of the mushroom typically discarded after commercial processing) in 2014.^[6] These residue-derived polysaccharides, fed to tumor-bearing mice, inhibited tumor growth and significantly upregulated NK cell activity, macrophage phagocytosis, and splenocyte proliferation.

Two findings stand out. First, the immune-active polysaccharides are present throughout the mushroom, not concentrated only in the cap or stipe. Processing waste retains meaningful bioactive content. Second, the NK cell activation in this model connects the in vitro macrophage findings to actual anti-tumor immune activity in a living system.

For how NK cell activation by P. eryngii polysaccharides compares mechanistically to NK cell activation by other medicinal mushrooms, see Pleurotus eryngii polysaccharides and NK cell activation and royal sun mushroom and NK cell enhancement in cancer patients.

What the Evidence Adds Up To

The polysaccharide immune picture for P. eryngii involves at minimum three layers: (1) direct innate immune activation through macrophage NF-κB and MAPK signaling, (2) NK cell and CTL priming via cytokine elevation, and (3) gut microbiota modulation through the unique β-1,6-glucan structure. A separate protein fraction contributes anti-inflammatory activity via COX-2 inhibition.

All of this evidence is preclinical. The macrophage signaling data is from cell culture experiments. The tumor model data is from mice. There is one human RCT for a related Pleurotus species (P. ostreatus, Tamogitake) showing a Th1 immune shift; the nearest human evidence but from a different species. Human clinical trials specifically for P. eryngii immune effects have not been conducted.

For the full human evidence picture and how P. eryngii compares in the evidence hierarchy, see king trumpet for immune support: evidence base and Pleurotus eryngii and macrophage activation.

The Bottom Line

King oyster mushroom (Pleurotus eryngii) produces β-1,6-glucan as a primary polysaccharide fraction, structurally distinct from the β-1,3-glucan in most medicinal mushrooms; this β-1,6-glucan modulates both immune function and gut microbiota (Wang et al., 2022). Extracellular β-glucan activates macrophage NF-κB, ERK1/2, JNK, and p38 MAPK pathways, with sulfated derivatives showing enhanced activity (Kim et al., 2017). A separately characterized polysaccharide fraction shows anti-inflammatory activity, reducing IL-1β and NO in macrophages (Ma et al., 2020). A novel P. eryngii protein reduces COX-2, NO, and PGE2 in macrophages independently of the polysaccharide fraction (Yuan et al., 2017). Processing residue polysaccharides inhibit tumor growth and activate NK cells in mouse models (Ma et al., 2014). Different extraction methods yield fractions with distinct immune activities (Zhang et al., 2020 review).

Frequently Asked Questions

What polysaccharides are in king oyster mushroom?

King oyster mushroom (Pleurotus eryngii) contains multiple polysaccharide fractions with different structures and biological activities. Its primary immune-active polysaccharide is β-1,6-glucan (Wang et al., Frontiers in Immunology, 2022), structurally distinct from the β-1,3-glucan found in most other medicinal mushrooms. Different extraction methods (hot water, alkaline, ultrasound-assisted) yield different fractions with distinct immunological profiles. The mushroom also contains immunologically active proteins alongside its polysaccharides.

How do king oyster polysaccharides affect the immune system?

Through multiple mechanisms: β-glucan fractions activate macrophages via NF-κB, ERK1/2, JNK, and p38 MAPK signaling pathways (Kim et al., 2017); polysaccharides from processing residue upregulate NK cell activity and macrophage phagocytosis in tumor-bearing mice (Ma et al., 2014); the β-1,6-glucan modulates gut microbiota composition in addition to direct immune cell effects (Wang et al., 2022); and a specific polysaccharide fraction reduces pro-inflammatory cytokines in stimulated macrophages (Ma et al., 2020). The net immune effect involves both activation and anti-inflammatory modulation depending on the specific fraction.

Is king oyster mushroom good for immunity?

Preclinical evidence supports immune-modulating effects through several mechanisms. The structural uniqueness of its β-1,6-glucan (distinct from other medicinal mushrooms) and the documented activation of macrophage signaling pathways in cell studies provides a mechanistic basis. In vivo animal studies confirm NK cell activation and anti-tumor immune activity. The closest human evidence is a double-blind RCT using a related Pleurotus species (oyster mushroom, Tamogitake) that showed Th1 immune enhancement. P. eryngii-specific human immune trials have not been published.

What is beta-glucan in king oyster mushrooms?

Beta-glucan is a polysaccharide made of glucose units linked in specific configurations. In most medicinal mushrooms, the immune-active form is β-1,3-glucan (glucose units linked at the 1-3 carbon position). King oyster mushroom (Pleurotus eryngii) produces β-1,6-glucan as its primary active polysaccharide, with glucose units linked at the 1-6 position. This structural difference gives it different receptor-binding properties and includes the unusual dual effect of modulating both immune cells and gut microbiota, documented in a 2022 Frontiers in Immunology study.

Does king oyster mushroom contain beta-1,3-glucan?

The primary characterized immune-active polysaccharide in Pleurotus eryngii is β-1,6-glucan, not β-1,3-glucan. This is distinct from most other medicinal mushrooms, which primarily contain β-1,3-glucan. Some commercial mushroom supplement testing measures total beta-glucan without distinguishing the linkage type, which can make it difficult to confirm the specific polysaccharide profile from supplement labels. Research fractions from P. eryngii that demonstrate immune activity have been characterized as β-1,6-linked rather than the more common β-1,3-linked structure.

Sources & References

1. 1RTHM-00801·Wang, Xue et al. (2022). “β-1,6-Glucan From Pleurotus eryngii Modulates the Immunity and Gut Microbiota..” Frontiers in immunology.Study breakdown →PubMed →↩
2. 2RTHM-00883·Kim, Yong Hyun et al. (2017). “Immunomodulatory Effects of Extracellular β-Glucan Isolated from the King Oyster Mushroom Pleurotus eryngii (Agaricomycetes) and Its Sulfated Form on Signaling Molecules Involved in Innate Immunity..” International journal of medicinal mushrooms.Study breakdown →PubMed →↩
3. 3RTHM-01247·Ma, Gaoxing et al. (2020). “Preparation of newly identified polysaccharide from Pleurotus eryngii and its anti-inflammation activities potential..” Journal of food science.Study breakdown →PubMed →↩
4. 4RTHM-01310·Zhang, Bingru et al. (2020). “Extraction, structure and bioactivities of the polysaccharides from Pleurotus eryngii: A review..” International journal of biological macromolecules.Study breakdown →PubMed →↩
5. 5RTHM-00933·Yuan, Biao et al. (2017). “Isolation of a novel bioactive protein from an edible mushroom Pleurotus eryngii and its anti-inflammatory potential..” Food & function.Study breakdown →PubMed →↩
6. 6RTHM-00624·Ma, Gaoxing et al. (2014). “Purification, characterization and antitumor activity of polysaccharides from Pleurotus eryngii residue..” Carbohydrate polymers.Study breakdown →PubMed →↩